CS204998B2 - Method of producing new benzimidazole derivatives - Google Patents
Method of producing new benzimidazole derivatives Download PDFInfo
- Publication number
- CS204998B2 CS204998B2 CS752989A CS298975A CS204998B2 CS 204998 B2 CS204998 B2 CS 204998B2 CS 752989 A CS752989 A CS 752989A CS 298975 A CS298975 A CS 298975A CS 204998 B2 CS204998 B2 CS 204998B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- formula
- salts
- benzimidazole derivatives
- group
- producing new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Description
Předmětem vynálezu je způsob výroby nových benzimidazolových derivátů a jejich solí.The present invention provides a process for the preparation of novel benzimidazole derivatives and their salts.
Nové deriváty benzimidazolu jsou sloučeniny obecného vzorce IThe novel benzimidazole derivatives are compounds of formula I
a jejich soli, přičemž v obecném vzorci I R1 je atom vodíku nebo skupina vzorceand salts thereof, wherein in the general formula IR 1 is a hydrogen atom or a group of the formula
II ~ocII ~ oc
O NO^ (fi) aO NO 2 (fi) a
R5 znamená alkoxykarbonylovou skupinu s 1 až 4 atomy uhlíku nebo skupinu vzorce II s podmínkou, že jeden ze symbolů R1 a R5 znamená skupinu vzorce II.R 5 is C 1 -C 4 alkoxycarbonyl or a group of formula II, provided that one of R 1 and R 5 is a group of formula II.
Označení „alkylový zbytek“ může znamenat alifatickou 9kupínu s rovným nebo rozvětveným řetězcem s 1 až 6 atomy Uhlíku (například methylovou, ethylovou, n-propylovou, isobutylovou atd.).The term "alkyl radical" may mean a straight or branched chain aliphatic 9 group having 1 to 6 carbon atoms (for example methyl, ethyl, n-propyl, isobutyl, etc.).
Soli sloučeniny obecného vzorce I se mohou tvořit s anorganickými nebo organickými kyselinami, například s kyselinou chlorovodíkovou, bromovodíkovou, sírovou, octovou, mravenčí, mléčnou, vinnou atd. Soli, které se mají používat pro terapií, se tvoří s farmaceuticky nezávadnými solemi.Salts of the compound of formula I may be formed with inorganic or organic acids, for example hydrochloric, hydrobromic, sulfuric, acetic, formic, lactic, tartaric, etc. Salts to be used for therapy are formed with pharmaceutically acceptable salts.
Zejména výhodné deriváty sloučeniny obecného vzorce I jsou následující sloučeniny:Particularly preferred derivatives of the compound of formula I are the following compounds:
1- (5-nitrofuryl-2-karbonyl) -methoxykarbonylaminobenzimidazoly, amidy N-(2‘-benzimidazolyl j -5-nitro-2-f urankarboxylové kyseliny.1- (5-Nitro-furyl-2-carbonyl) -methoxycarbonylaminobenzimidazoles, N- (2'-benzimidazolyl) -5-nitro-2-furancarboxylic acid amides.
Předmětem vynálezu je způsob výroby sloučenin obecného vzorce I a jejich solí, kde význam R1 a Rs je stejný jako shora, jehož podstata spočívá v tom, že se sloučenina obecného vzorce IV,The present invention provides a process for preparing compounds of formula I and salts thereof wherein the meaning of R 1 and R are the same as above, which is characterized in that a compound of formula IV,
kdewhere
R6 znamená atom vodíku nebo alkoxykarbonyl s 1 až 6 atomy uhlíku v alkoxylu a s rovným nebo rozvětveným řetězcem alkylu, nechá reagovat s chloridem 5-nitro-2-furoylkarboxylové kyseliny a potom se získaná sloučenina obecného vzorce I popřípadě převede ve své soli.R 6 is hydrogen or C 1 -C 6 alkoxycarbonyl, straight or branched chain alkyl, reacted with 5-nitro-2-furoylcarboxylic acid chloride, and then optionally converted to its salt.
Při výhodném způsobu provedení se reakce může provádět s výhodou v organickém rozpouštědle v přítomnosti bazické substance. V případě použití esteru kyseliny je výhodné odstraňovat kontinuálně alkohol. Jestliže se reakce provádí za použití volné kyseliny, pracuje se s výhodou v přítomnosti kondenzačního prostředku (například dicyklohexy Ikarbodiimidu) v dimethylf ormamidu.In a preferred embodiment, the reaction can be carried out preferably in an organic solvent in the presence of a basic substance. If an acid ester is used, it is preferable to continuously remove the alcohol. If the reaction is carried out using the free acid, it is preferably carried out in the presence of a condensation agent (e.g. dicyclohexylcarbodiimide) in dimethylformamide.
Sloučeniny obecného vzorce I se mohou převést na své soli obvyklými způsoby reakcí sloučeniny obecného vzorce I s přibližně ekvimolárním množstvím kyseliny v přítomnosti organického rozpouštědla.The compounds of formula I can be converted to their salts by conventional methods by reacting a compound of formula I with an approximately equimolar amount of acid in the presence of an organic solvent.
Sloučeniny obecného vzorce I a jejich soli jsou především vynikajícími fungicidy a mohou se používat jak v humánní, tak i veterinární medicíně a také v zemědělství.In particular, the compounds of the formula I and their salts are excellent fungicides and can be used in both human and veterinary medicine and also in agriculture.
Další podrobnosti lze seznati z dále uvedených příkladů, aniž se vynález omezuje na tyto příklady.Further details can be learned from the examples below without limiting the invention to these examples.
PřikladlHe did
19,1 g (0,1 molu) 2-methoxykarbonyl)benzimidazolu se suspenduje ve 250 ml dioxanu a k roztoku se při 50 až 60 °C přidá 10 g triethylaminu. Potom se během půl hodiny přidá k reakční směsi 17,5 g (0,1 molu) chloridu kyseliny 5-nltro-2-furankarboxylové. Započne exotermní reakce. Reakční směs se vaří 3 hodiny pod zpětným chladičem, potom se míchá půl hodiny při 15 °C a promyje vodou. Získá se 25,2 g l-(5-nitrof ury 1-2-karbonyl ] -2-methoxykarbonylaminobenzimidazolu. T. t. 175 °C (rozklad). Příklad 219.1 g (0.1 mol) of 2-methoxycarbonyl) benzimidazole are suspended in 250 ml of dioxane and 10 g of triethylamine are added at 50-60 ° C. Then, 17.5 g (0.1 mol) of 5-nitro-2-furancarboxylic acid chloride was added to the reaction mixture over half an hour. Exothermic reactions begin. The reaction mixture was refluxed for 3 hours, then stirred at 15 ° C for half an hour and washed with water. 25.2 g of 1- (5-nitrophenyl-2-carbonyl) -2-methoxycarbonylaminobenzimidazole, m.p. 175 DEG C. (decomposition), are obtained.
13,3 g (0,1 molu) 2-aminobenzimidazolu se suspenduje ve 250 ml dioxanu a k roztoku se přidá 10 g triethylaminu. Reakční směs se zahřeje na 60 °C a při této teplotě se přidá 17,5 g (0,1 molu) chloridu 5-nitro-2-furankarboxylové kyseliny. Reakční směs se míchá 2 hodiny při 60 °C, potom se ochladí na 15 °C. Získá se 25,5 g amidu N- (2‘-benzimidazolyl)-5-nitrofurankarboxylové kyseliny. T. t. 240 až 242 °C.13.3 g (0.1 mol) of 2-aminobenzimidazole are suspended in 250 ml of dioxane and 10 g of triethylamine are added to the solution. The reaction mixture was heated to 60 ° C and 5-nitro-2-furancarboxylic acid chloride (17.5 g, 0.1 mol) was added at this temperature. The reaction mixture was stirred at 60 ° C for 2 hours, then cooled to 15 ° C. 25.5 g of N- (2‘-benzimidazolyl) -5-nitrofurancarboxylic acid amide is obtained. Mp 240-242 ° C.
Claims (2)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU74CI00001473A HU171244B (en) | 1974-05-02 | 1974-05-02 | Process for preparing new derivatives of the benzimidazole and herbicides containing such compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
CS204998B2 true CS204998B2 (en) | 1981-04-30 |
Family
ID=10994517
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS752989A CS204999B2 (en) | 1974-05-02 | 1975-04-29 | Method of producing new banzimidazole derivatives |
CS752989A CS204998B2 (en) | 1974-05-02 | 1975-04-29 | Method of producing new benzimidazole derivatives |
CS752989A CS205000B2 (en) | 1974-05-02 | 1975-04-29 | Fungicide means |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS752989A CS204999B2 (en) | 1974-05-02 | 1975-04-29 | Method of producing new banzimidazole derivatives |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS752989A CS205000B2 (en) | 1974-05-02 | 1975-04-29 | Fungicide means |
Country Status (11)
Country | Link |
---|---|
CS (3) | CS204999B2 (en) |
DD (1) | DD120194A1 (en) |
DK (1) | DK190675A (en) |
FI (1) | FI751289A (en) |
HU (1) | HU171244B (en) |
IL (1) | IL47185A0 (en) |
IN (1) | IN141703B (en) |
PL (3) | PL99545B1 (en) |
SE (1) | SE7505025L (en) |
SU (2) | SU584769A3 (en) |
YU (2) | YU109175A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9216968B2 (en) * | 2011-08-18 | 2015-12-22 | Nippon Shinyaku Co., Ltd. | Heterocyclic derivative and pharmaceutical drug |
-
1974
- 1974-05-02 HU HU74CI00001473A patent/HU171244B/en unknown
-
1975
- 1975-04-26 IN IN847/CAL/75A patent/IN141703B/en unknown
- 1975-04-28 IL IL47185A patent/IL47185A0/en unknown
- 1975-04-29 FI FI751289A patent/FI751289A/fi not_active Application Discontinuation
- 1975-04-29 CS CS752989A patent/CS204999B2/en unknown
- 1975-04-29 DD DD185755A patent/DD120194A1/xx unknown
- 1975-04-29 CS CS752989A patent/CS204998B2/en unknown
- 1975-04-29 SE SE7505025A patent/SE7505025L/en unknown
- 1975-04-29 YU YU01091/75A patent/YU109175A/en unknown
- 1975-04-29 CS CS752989A patent/CS205000B2/en unknown
- 1975-04-30 SU SU7502131951A patent/SU584769A3/en active
- 1975-05-01 DK DK190675A patent/DK190675A/en not_active Application Discontinuation
- 1975-05-02 PL PL1975180100A patent/PL99545B1/en unknown
- 1975-05-02 PL PL1975193637A patent/PL106064B1/en unknown
- 1975-05-02 PL PL1975193636A patent/PL102170B1/en unknown
-
1976
- 1976-04-15 SU SU762348905A patent/SU626694A3/en active
-
1981
- 1981-04-27 YU YU01081/81A patent/YU108181A/en unknown
Also Published As
Publication number | Publication date |
---|---|
PL99545B1 (en) | 1978-07-31 |
PL193637A1 (en) | 1978-02-27 |
HU171244B (en) | 1977-12-28 |
IN141703B (en) | 1977-04-09 |
SU626694A3 (en) | 1978-09-30 |
YU109175A (en) | 1982-02-28 |
DD120194A1 (en) | 1976-06-05 |
CS205000B2 (en) | 1981-04-30 |
IL47185A0 (en) | 1975-06-25 |
SE7505025L (en) | 1975-11-03 |
PL193636A1 (en) | 1978-02-13 |
PL102170B1 (en) | 1979-03-31 |
SU584769A3 (en) | 1977-12-15 |
FI751289A (en) | 1975-11-03 |
PL106064B1 (en) | 1979-11-30 |
DK190675A (en) | 1975-11-03 |
YU108181A (en) | 1982-02-28 |
CS204999B2 (en) | 1981-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SU1333234A3 (en) | Method of producing the derivatives of n-phenylbenzamide or salts thereof | |
BR112012007869B1 (en) | ERGOTIONEIN AND DERIVATIVES SYNTHESIS PROCESS | |
JPS6058750B2 (en) | Method for producing N-(1-benzylpyrrolidinyl-2-methyl)-substituted benzamide derivative or salts thereof | |
RU2039043C1 (en) | 1-hexyl-4- phenyl-4-biperidine carboxamide n-substituted derivative or pharmaceutically acceptable salt thereof, and process for preparing thereof | |
JPS6053027B2 (en) | Tetrazole derivative | |
JPS58194873A (en) | 1-(3,4,5-trimethoxycinnamoyl)-4-aminocarbonylmethyl- substituted piperazine derivative | |
US2543345A (en) | Method of preparing glutamic acid amides | |
CS204998B2 (en) | Method of producing new benzimidazole derivatives | |
JPS6332073B2 (en) | ||
JPH0361667B2 (en) | ||
FI58118C (en) | PROCEDURE FOR THE FRAMSTATION OF N- (1-EECL-ALPHA-PYRROLIDYLMETHYL) -2-METHOXY-5-SULFAMIDOBENZAMIDE | |
JP2017525748A (en) | Synthesis of cyclocreatine and its analogues | |
US3821238A (en) | 2-(b-aminoethylsulfonylamine)thiazole | |
US4105689A (en) | Production of N-substituted 2-carbamoyl phosphinic acids | |
JPH05503718A (en) | Method for dividing optically isomeric hydantoin | |
NO750713L (en) | ||
JP3046258B2 (en) | Method for producing 1-chlorocarbonyl-4-piperidinopiperidine or hydrochloride thereof | |
JPS5910345B2 (en) | Production method of thiourea compound | |
US3887577A (en) | Process for the preparation of 2-imino derivatives of substituted imidazoles | |
JPS591268B2 (en) | Thiadiazole derivative | |
US4804765A (en) | Process for synthesizing N-[(1'-allyl-2'pyrrolidinyl) methyl]2-methoxy-4,5-azimidobenzamide | |
JPS6261966A (en) | Propionamidine derivatives and manufacture | |
JPS6360969A (en) | Production of imidazole derivative | |
KR820001277B1 (en) | Process for preparation of 5-substituted picolinic acid derivatives | |
KR820002295B1 (en) | Process for preparing n-(2-pyrrolidinyl alkyl) substituted benzamides |